Telehealth came out of the pandemic with real momentum. Regulatory flexibilities unlocked new prescribing models, reimbursement parity gave companies a commercial foundation to build on,…
Telehealth came out of the pandemic with real momentum. Regulatory flexibilities unlocked new prescribing models, reimbursement parity gave companies a commercial foundation to build on,…
The BioTech hiring market took a hard hit in 2023 and through much of 2024. Rising interest rates, a difficult IPO window, and a significant…
The Head of AI title is everywhere right now. Boards are asking whether they need one. Founders are debating what the role should own. And…
Real World Evidence has moved from the periphery of HealthTech to the centre of it. Regulators are accepting RWE in support of label expansions and…
The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
The Chief Product Officer role in HealthTech has always been more complex than its equivalent in consumer software. Clinical validation, regulatory pathway, patient safety obligations…